Kitanaka Nobue Department
Hyogo Medical University(Specialty Division)
Pharmacology, Basic Medicine Seminars
Position
■ Journal
1.
Original article
Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats. 2010/02
2.
Original article
Withdrawal from fixed-dose injection of methamphetamine decreases cerebral levels of 3-methoxy-4-hydroxyphenylglycol and induces the expression of anxiety-related behavior in mice. 2010/05
3.
Original article
Histamine H3 receptor agonists decrease hypothalamic histamine levels and increase stereotypical biting in mice challenged with methamphetamine. 2011/10
4.
Original article
A single administration of methamphetamine to mice early in the light period decreases running wheel activity observed during the dark period. 2012/01
5.
Original article
Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice. 2012/02
6.
Original article
Attenuation of methamphetamine-induced conditioned place preference in mice after a drug-free period and facilitation of this effect by exposure to a running wheel 2012/07
7.
Original article
Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine. 2012/10
8.
Original article
The selective μ opioid receptor antagonist β-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice. 2013/07
9.
Original article
Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice. 2014/04
10.
Original article
Memory impairment and reduced exploratory behavior in mice after administration of systemic morphine 2015/05
11.
Original article
Pretreatment or posttreatment with aripiprazole attenuates methamphetamine-induced stereotyped behavior in mice 2015/09
12.
Introduction
Brain histamine N-methyltransferase as a possible target of treatment for methamphetamine overdose 2016/03
13.
Original article
The absence of the SOD1 gene causes abnormal monoaminergic neurotransmission and motivational impairment-like behavior in mice 2016/10
14.
Introduction
How the histamine N-methyltransferase inhibitor metoprine alleviates methamphetamine reward 2017/05
15.
Original article
Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex 2018
16.
Original article
Psychotomimetic-like behavioral effects of memantine in the mouse 2018/02
17.
Introduction
Lithium pharmacology and a potential role of lithium on methamphetamine abuse and dependence 2019/05
18.
Original article
In vivo evaluation of effects of histamine H3 receptor antagonists on methamphetamine-induced hyperlocomotion in mice 2020
19.
Original article
Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice 2021
20.
Introduction
Are histamine H3 antagonists the definitive treatment for acute methamphetamine intoxication? 2022
21.
Original article
Neuroprotective effect of oxytocin on cognitive dysfunction, DNA damage, and intracellular chloride disturbance in young mice after cranial irradiation 2022
22.
Original article
Glycogen synthase kinase-3 inhibitors block morphine-induced locomotor activation, Straub tail, and depression of rearing in mice via a possible central action 2023
23.
Original article
Kamishoyosan and Kamikihito protect against decreased KCC2 expression via neuroinflammation induced by the P. gingivalis lipopolysaccharide treatment in PC-12 cells and improve behavioral abnormalities in male mice 2023/11
24.
Introduction
Therapeutic potential for KCC2-targeted neurological diseases 2023/11
Chapter 7. Regulating the expression patterns of bizarre behavior: a therapeutic option for amphetamine-type drug-induced stereotypy?, Advances in Psychology Research Volume 60 2009
2.
Contributor
Chapter 5. Isoliquiritigenin, a licorice flavonoid, inhibits methamphetamine-induced hyperlocomotion but not stereotypy or conditioned place preference in mice, Methamphetamines: Abuse, Health Effects and Treatment Options 2012/06
3.
Contributor
Chapter 12. Anhedonia in mouse models of methamphetamine-induced drug seeking behavior, Anhedonia: A Comprehensive Handbook Volume I 2014/03
4.
Contributor
Glycogen synthase kinase-3beta and methamphetamine abuse liability., Advances in Health and Disease 2022
■ Presentation
1.
Hypothalamic histamine levels are negatively correlated with expression frequency of methamphetamine-induced stereotypical biting in mice (Poster presentation,General Lecture) 2012/09/30
2.
Mechanism of thymidine incorporation into astrocytic acid insoluble fraction via SLC28 and SLC29 on oxidative stress DNA injury (Poster presentation,General Lecture) 2012/09/30
3.
Effects of experience of running wheel on methamphetamine-induced conditioned place preference in mice (Poster presentation,General Lecture) 2012/10/13
Neurobiological and behavioral changes in SOD1 knockout mice (Poster presentation,General Lecture) 2013/06/20
6.
Agmatine attenuates methamphetamine-induced stereotypical behavior and hyperlocomotion in mice (Poster presentation,General Lecture) 2013/11/13
7.
Opioid receptor antagonists attenuate methamphetamine-induced stereotypical behavior in mice via mu opioid receptors (Poster presentation,General Lecture) 2013/11/13
8.
Aripiprazole inhibits methamphetamine-induced stereotypy in mice (Poster presentation,General Lecture) 2014/09/12
9.
Exogenous agmatine inhibits methamphetamine-induced stereotypy and hyperlocomotion in mice (Poster presentation,General Lecture) 2014/09/12
10.
Relation with decrease of thymidine incorporation and cell death by oxidative stress in cultured astrocytes (Poster presentation,General Lecture) 2014/09/12
11.
Attenuation by agmatine of METH-induced stereotypy via a change in hypothala mic histamine contents (Poster presentation,General Lecture) 2014/09/29
12.
Regulation of Ca2+ on nucleoside transporter in cultured astrocytes by oxidative stress (Poster presentation,General Lecture) 2015/03/19
13.
A single administration of morphine induces memory impairment and reduced exploratory behavior in mice (Poster presentation,General Lecture) 2015/03/20
14.
Pretreatment or post-treatment of aripiprazole attenuates methamphetamine-induced stereotypy in mice (Poster presentation,General Lecture) 2015/03/20
Effects of VMAT inhibitors on methamphetamine-induced hyperlocomotion and stereotyped behaviors in mice (Poster presentation,General Lecture) 2016/07/21
17.
Influence of another nucleosides on hydrogen peroxide-induced thymidine incorporation into cultured astrocytes (Poster presentation,General Lecture) 2016/07/21
18.
Memantine induces stereotyped sniffing which is blocked by haloperidol and betahistine in mice (Poster presentation,General Lecture) 2016/07/21
19.
17α-estradiol regulates SPAK-KCC2 activity via GPR30 in the hippocampus of repeated stressed OVX mice (Oral presentation,General Lecture) 2017/03/15
20.
Influence of intracellular calcium ion on oxidative stress injury-induced thymidine incorporation (Poster presentation,General Lecture) 2017/03/15
21.
Neonatal maternal separation delays the timing of excitatory-to-inhibitory GABA switch via down-regulation of KCC2 (Poster presentation,General Lecture) 2017/03/16
22.
Tetrabenazine attenuates morphine-induced hyperlocomotion in mice (Poster presentation,General Lecture) 2017/03/16
23.
The central and peripheral effects of memantine in mice (Poster presentation,General Lecture) 2017/03/16
24.
Pitolisant, a histamine H3 receptor inverse agonist, attenuates methamphetamine-induced hyperlocomotion in mice via histamine H1 receptors (Poster presentation,General Lecture) 2017/07/22
25.
Agmatine increases brain histamine levels and attenuates methamphetamine-induced hyperlocomotion and stereotyped behaviors in mice (Poster presentation,General Lecture) 2018/07/27
Analysis of hydrogen peroxide resistance mechanism on hydrogen peroxide resistant cancer cells (Poster presentation,General Lecture) 2019/03/15
28.
Involvement of ALOX in resistance or sensitivity of cancer treatment via plasma membrane oxidation state (Oral presentation,General Lecture) 2019/03/15
29.
Abnormal monoaminergic neurotransmission and motivational impairment-like behavior in SOD1 knockout (KO) mice. (Poster presentation,General Lecture) 2019/04/06
30.
Expression of nucleoside transporters and hydrogen peroxide-induced
thymidine incorporation in astrocytes (Poster presentation,General Lecture) 2020/03/16